Pilot & Feasibility
Protocols & Methods
Reagents & Resources
Tissues & Samples
IMPC / KOMP Data
Pilot & Feasibility
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS
Jonathan Newman on 8/29/2017
Journal of the American College of Cardiology
Volume : Pages
70 : 883 - 893
Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease
(CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D
meet recommended guidelines for CVD prevention. The burden of T2D is increasing:
by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with
T2D will comprise an increasingly large proportion of the CVD population. The
authors believe it is imperative that we expand the use of therapies proven to
reduce CVD risk in patients with T2D. The authors summarize evidence and
guidelines for lifestyle (exercise, nutrition, and weight management) and CVD
risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and
the use of aspirin) management for the prevention of CVD among patients with
T2D. The authors believe appropriate lifestyle and CVD risk factor management
has the potential to significantly reduce the burden of CVD among patients with
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!